MobileODT Secures $6.8M Series B Funding led by OrbiMed

Today, MobileODT announced it has raised an additional $6.825 million in a Series B fundraising round led by OrbiMed Advisors – a leading healthcare venture fund. Previous investors Tristel plc.  also participated in the round. MobileODT has raised over $13 million to date.

MobileODT plans to use the Series B funding to continue to expand its product portfolio and IP as well as grow sales and marketing efforts in the US and international markets in which it is currently selling.

Ariel Beery, CEO & Chairman of the Board said “We are excited to accelerate our growth through this financing round led by some of the world’s best strategic and healthcare investors. This financing together with the recent launch of the third generation mobile colposcope, the FDA cleared EVA System, will enable us to fulfill our promise to reach every patient.”

Read more